[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,331,456
  • Shares Outstanding, K 5,699,674
  • Annual Sales, $ 62,579 M
  • Annual Income, $ 7,771 M
  • EBIT $ 19,384 M
  • EBITDA $ 25,976 M
  • 60-Month Beta 0.34
  • Price/Sales 2.35
  • Price/Cash Flow 5.87
  • Price/Book 1.72

Options Overview Details

View History
  • Implied Volatility 19.63% (-0.39%)
  • Historical Volatility 20.08%
  • IV Percentile 2%
  • IV Rank 8.68%
  • IV High 34.15% on 10/10/25
  • IV Low 18.25% on 08/18/25
  • Expected Move (DTE 7) 0.46 (1.73%)
  • Put/Call Vol Ratio 0.66
  • Today's Volume 125,473
  • Volume Avg (30-Day) 103,407
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 2,634,155
  • Open Int (30-Day) 2,488,235
  • Expected Range 26.02 to 26.94

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.84
  • Number of Estimates 6
  • High Estimate $0.94
  • Low Estimate $0.69
  • Prior Year $0.87
  • Growth Rate Est. (year over year) -3.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.89 +10.74%
on 07/08/26
26.53 -0.28%
on 08/07/26
+2.39 (+9.91%)
since 07/07/26
3-Month
23.62 +12.01%
on 07/06/26
26.53 -0.30%
on 05/27/26
-0.02 (-0.09%)
since 05/07/26
52-Week
23.58 +12.20%
on 09/25/25
28.75 -7.96%
on 04/02/26
+2.23 (+9.19%)
since 08/07/25

Most Recent Stories

More News
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine

Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!

AZN : 160.26 (-0.50%)
MRNA : 58.34 (+8.32%)
RHHBY : 57.2400 (+1.90%)
PFE : 26.55 (+1.34%)
PFE Q2 Deep Dive: New Products Offset COVID Decline, R&D Pipeline Expands

PFE Q2 Deep Dive: New Products Offset COVID Decline, R&D Pipeline Expands

PFE : 26.55 (+1.34%)
Pfizer’s (NYSE:PFE) Q2 CY2026: Beats On Revenue

Pfizer’s (NYSE:PFE) Q2 CY2026: Beats On Revenue

PFE : 26.55 (+1.34%)
Pfizer: Q2 Earnings Snapshot

Pfizer: Q2 Earnings Snapshot

PFE : 26.55 (+1.34%)
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Focused Execution Drove 18% Operational Revenue Growth of Launched and Acquired Products (1) Advancing Robust Late-Stage Pipeline, with Several Key Pivotal Readouts...

PFE : 26.55 (+1.34%)
Stocks Set to Open Higher as Oil Sinks on U.S.-Iran Deal Hopes, Jobs Data and Earnings Awaited

September S&P 500 E-Mini futures (ESU26) are up +0.57%, and September Nasdaq 100 E-Mini futures (NQU26) are up +0.47% this morning, pointing to a higher open on Wall Street as oil prices sank after U.S....

GOOGL : 354.19 (-1.00%)
UAL : 130.01 (+0.69%)
AAPL : 312.26 (-0.05%)
SNDK : 1,231.94 (-2.12%)
NQU26 : 29,705.25 (+0.74%)
PFE : 26.55 (+1.34%)
SHOP : 150.01 (+1.74%)
MSFT : 500.14 (+0.06%)
TSLA : 328.01 (+2.65%)
FERG : 257.26 (+1.54%)
WDC : 434.65 (-3.74%)
ESU26 : 7,761.75 (+0.35%)
Pfizer (PFE) Q2 Earnings: What To Expect

Pfizer (PFE) Q2 Earnings: What To Expect

PFE : 26.55 (+1.34%)
Earnings, PMI and Other Key Things to Watch this Week

Markets enter an earnings-dominated week with a huge concentration of corporate results spanning technology, industrials, healthcare, consumer discretionary, and entertainment sectors. This will provide...

APP : 346.25 (+3.15%)
ANET : 189.51 (-3.95%)
SPOT : 491.31 (+3.42%)
SNDK : 1,231.94 (-2.12%)
MRK : 128.35 (-0.02%)
PFE : 26.55 (+1.34%)
MCD : 273.84 (-0.88%)
DIS : 105.13 (+0.43%)
SHOP : 150.01 (+1.74%)
SPCX : 129.46 (+12.65%)
CAT : 845.79 (-1.30%)
AMD : 480.11 (-1.87%)
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Two pivotal studies of LITFULO™ (ritlecitinib) in nonsegmental vitiligo met their co-primary endpoints, showing significant improvement in facial and total repigmentation versus placebo at Week 52 ...

PFE : 26.55 (+1.34%)
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages ...

PFE : 26.55 (+1.34%)
BNTX : 93.03 (+2.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 26.72
2nd Resistance Point 26.46
1st Resistance Point 26.33
Last Price 26.56
1st Support Level 25.94
2nd Support Level 25.68
3rd Support Level 25.55

See More

52-Week High 28.75
Fibonacci 61.8% 26.77
Last Price 26.56
Fibonacci 50% 26.16
Fibonacci 38.2% 25.55
52-Week Low 23.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.